Online citations, reference lists, and bibliographies.
← Back to Search

Solid Lipid And Polymeric Nanoparticles For Drug Delivery

J. Pedraz, G. Orive, M. Igartua, A. R. Gascón, Rosa M. Hernández, M. A. Solinís, A. Esquisabel
Published 2007 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
The sections in this article are Introduction SLNs Introduction Composition Production Processes Preparation Techniques Scaling-up, Sterilization and Drying Drug Incorporation, Loading, Incorporation Efficiency, Nanoparticle Recovery and Drug Release Drug Incorporation Drug Loading Determination of Nanoparticle Recovery and Drug Incorporation Efficiency Drug Release Related Structures and Stability Analytical Characterization of SLNs Particle Size The ζ Potential Crystallinity and Polymorphism and Colloidal Structures Applications Gene Therapy Peptide and Protein Delivery Low-soluble Drugs Topical and Transdermal Administration Cosmetic Applications for SLNs Polymeric Nanoparticles Introduction Nanoparticle Preparation Methods Nanoparticles Prepared by In Situ Polymerization of Monomers Nanoparticles Prepared from Preformed Polymers Characterization of Polymeric Nanoparticles Pharmaceutical Applications of Nanoparticles Protein Delivery Protein Delivery by Mucosal Routes Vaccine Adjuvants
This paper references
10.1016/S0168-3659(99)00223-0
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties.
V. Jenning (2000)
10.1016/S0169-409X(00)00120-4
Mucoadhesive nanoparticulate systems for peptide drug delivery.
H. Takeuchi (2001)
10.1016/S0939-6411(01)00167-9
Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media.
E. Zimmermann (2001)
10.1016/S0939-6411(98)00074-5
Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase.
C. Freitas (1999)
10.1023/B:PHAM.0000041463.56768.ec
Application of Novel Solid Lipid Nanoparticle (SLN)-Gene Vector Formulations Based on a Dimeric HIV-1 TAT-Peptide in Vitro and in Vivo
C. Rudolph (2004)
10.1016/S0264-410X(02)00435-8
Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres.
I. Gutierro (2002)
10.2165/00137696-200402040-00005
Entrapment of bioactive molecules in poly (alkylcyanoacrylate) nanoparticles
K. Krauel (2004)
10.1016/J.ADDR.2004.02.014
Nanoparticle and targeted systems for cancer therapy.
L. Brannon-Peppas (2004)
10.1002/ART.10198
Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance.
W. U. Kim (2002)
10.1016/J.EJPB.2003.10.015
Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer.
K. Tabatt (2004)
10.1023/A:1025065418309
Physicochemical Investigations on Solid Lipid Nanoparticles and on Oil-Loaded Solid Lipid Nanoparticles: A Nuclear Magnetic Resonance and Electron Spin Resonance Study
K. Jores (2004)
10.1016/S0378-5173(97)04885-0
Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters
A. J. Almeida (1997)
10.1016/S0928-0987(00)00081-6
Preparation and characterization of solid lipid nanospheres containing paclitaxel.
R. Cavalli (2000)
10.1016/S0378-5173(02)00639-7
Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters.
P. Shahgaldian (2003)
10.1016/S0378-5173(02)00268-5
Incorporation of cyclosporin A in solid lipid nanoparticles (SLN).
E. Ugazio (2002)
10.1023/A:1015871809313
Polyalkylcyanoacrylate Nanoparticles as Polymeric Carriers for Antisense Oligonucleotides
C. Chavany (2004)
10.1016/S0939-6411(01)00245-4
Factors influencing the entrapment of hydrophilic compounds in nanocapsules prepared by interfacial polymerisation of water-in-oil microemulsions.
T. Pitaksuteepong (2002)
10.1016/0378-5173(93)90075-Q
Study of the mechanisms of formation of nanoparticles and nanocapsules of polyisobutyl-2-cyanoacrylate
M. Gallardo (1993)
10.1081/PDT-120022158
Scale-Up and Optimization of an Evaporative Drying Process Applied to Aqueous Dispersions of Solid Lipid Nanoparticles
E. Marengo (2003)
10.1016/S0928-0987(03)00104-0
Effect of colloidal carriers on ascorbyl palmitate stability.
J. Kristl (2003)
10.1016/J.ADDR.2003.07.002
Understanding endocytic pathways and intracellular trafficking: a prerequisite for effective design of advanced drug delivery systems.
A. Jones (2003)
10.1089/HUM.1996.7.14-1701
Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung.
E. Lee (1996)
10.1016/J.ADDR.2003.12.002
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
10.1038/NM0903-1100
News Feature: Technologies that deliver
P. Basu (2003)
10.1023/A:1016042504830
Atomic Force Microscopy Studies of Solid Lipid Nanoparticles
A. Mühlen (2004)
10.1016/J.IJPHARM.2004.12.027
Effect of hexacosanol on the characteristics of novel sustained-release allopurinol solid lipospheres (SLS): factorial design application and product evaluation.
I. El-Gibaly (2005)
10.1046/J.0014-2956.2001.02671.X
Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat.
M. Silhol (2002)
10.1016/S0378-5173(96)04731-X
Biodegradation of solid lipid nanoparticles as a function of lipase incubation time
R. Mueller (1996)
10.1016/S0939-6411(97)00150-1
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)
10.1016/J.BIOMATERIALS.2005.11.043
A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors.
Yong-Il Chung (2006)
10.1016/S0939-6411(00)00084-9
Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?
T. Jung (2000)
10.1111/j.1365-2222.2004.01884.x
Allergen‐loaded biodegradable poly(d,l‐lactic‐co‐glycolic) acid nanoparticles down‐regulate an ongoing Th2 response in the BALB/c mouse model
I. Schoell (2004)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1023/A:1012043315093
Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant
R. Mueller (2004)
10.1002/(SICI)1097-4628(19970314)63:11<1481::AID-APP10>3.0.CO;2-5
Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin
D. A. Norris (1997)
10.1016/S0962-8924(00)01771-2
Protein transduction: unrestricted delivery into all cells?
S. Schwarze (2000)
10.1080/02652040500162436
SLN and NLC for topical delivery of ketoconazole
E. Souto (2005)
10.1211/0022357044959
Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
L. Hu (2004)
10.1016/S0168-3659(01)00277-2
Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C.
A. Kozłowski (2001)
10.1001/JAMA.285.5.606
Prospects for vaccines to protect against AIDS, tuberculosis, and malaria.
N. Letvin (2001)
10.1016/0169-409X(95)00039-A
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
G. Storm (1995)
10.1016/S0378-5173(02)00180-1
Nanostructured lipid matrices for improved microencapsulation of drugs.
R. Mueller (2002)
10.1002/JPS.2600840415
Preparation and Structure of a Water‐in‐Oil Cream Containing Lipid Nanoparticles
T. D. Vringer (1995)
10.1016/S0378-5173(98)00236-1
Solid lipid nanoparticles as drug carriers: II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate in mice
H. Heiati (1998)
10.1016/J.JCONREL.2004.09.014
Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
Carrie S W Chong (2005)
10.1023/A:1016063109373
Stable Formulations of Recombinant Human Growth Hormone and Interferon-γ for Microencapsulation in Biodegradable Mircospheres
J. Cleland (2004)
10.1615/CRITREVEUKARGENEEXPR.V11.I1-3.10
An update on angiogenesis therapy.
J. Davda (2001)
10.1111/j.2042-7158.1979.tb13510.x
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties
P. Couvreur (1979)
10.1073/PNAS.84.21.7413
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
P. Felgner (1987)
10.1016/S0169-409X(01)00110-7
Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications.
M. C. Pedroso de Lima (2001)
10.1023/A:1015874121860
Optimization of Spray-Dried and -Congealed Lipid Micropellets and Characterization of Their Surface Morphology by Scanning Electron Microscopy
T. Eldem (2004)
10.1016/S0168-3659(99)00247-3
Nanosphere based oral insulin delivery.
G. Carino (2000)
10.1023/A:1018888927852
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Shicheng Yang (2004)
10.1016/S0168-3659(01)00486-2
Design of biodegradable particles for protein delivery.
A. Vila (2002)
10.1016/S0378-5173(01)00936-X
Development and characterization of solid lipid nanoparticles loaded with magnetite.
M. Igartua (2002)
10.1016/S0378-5173(02)00081-9
Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization.
F. Hu (2002)
10.1016/S0939-6411(97)00172-0
Spray-drying of solid lipid nanoparticles (SLN TM).
C. Freitas (1998)
10.1016/S0939-6411(00)00143-0
Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers.
R. Gref (2001)
10.1016/J.EJPB.2005.02.006
Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN).
T. Göppert (2005)
10.1081/DDC-100102197
Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method.
J. Barichello (1999)
10.1016/S0378-5173(99)00424-X
Influence of different parameters on reconstitution of lyophilized SLN.
E. Zimmermann (2000)
10.1016/S0378-5173(00)00471-3
Scale-up of the preparation process of solid lipid nanospheres. Part I.
E. Marengo (2000)
10.1080/026520499288690
Solid lipid nanoparticles (SLN/Lipopearls)--a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products.
A. Dingler (1999)
10.1016/S0142-9612(99)00125-8
Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles.
C. E. Soma (2000)
10.1016/S0142-9612(02)00216-8
Evaluation of cationic solid lipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cells.
C. Erni (2002)
10.1046/j.1467-2494.2001.00087.x
A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles
S. Wissing (2001)
10.1016/S0378-5173(00)00378-1
Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.
V. Jenning (2000)
10.1177/026119290203000407
Stable Biocompatible Adjuvants — a New Type of Adjuvant Based on Solid Lipid Nanoparticles: A Study on Cytotoxicity, Compatibility and Efficacy in Chicken
C. Olbrich (2002)
10.1016/J.JCONREL.2005.03.009
Preparation and characterization of biodegradable nanoparticles entrapping immunodominant peptide conjugated with PEG for oral tolerance induction.
Woo-kyoung Lee (2005)
10.1080/02652040010018119
Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro- and nanoparticles.
M. Demirel (2001)
10.1016/J.JBIOTEC.2004.06.007
Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
R. H. Muller (2004)
10.1016/S0939-6411(02)00083-8
Enhanced brain targeting by synthesis of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine and incorporation into solid lipid nanoparticles.
J. X. Wang (2002)
10.1016/J.COPBIO.2003.10.007
Drug delivery in biotechnology: present and future.
G. Orive (2003)
10.1016/S0168-3659(02)00025-1
Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).
L. Mu (2002)
10.1016/S0378-5173(98)00404-9
Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures.
C. Olbrich (1999)
10.1016/S0939-6411(03)00020-1
Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins.
Alix Dubes (2003)
10.1016/J.IJPHARM.2004.12.030
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin.
M. Garcia-Fuentes (2005)
10.1016/0378-5173(96)04539-5
Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles
R. Mueller (1996)
10.1016/J.JCONREL.2004.07.023
HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes.
L. Hyndman (2004)
10.1007/s11095-005-7148-5
Solid Lipid Nanoparticles (SLN) and Oil-Loaded SLN Studied by Spectrofluorometry and Raman Spectroscopy
K. Jores (2005)
10.1146/ANNUREV.IY.07.040189.001045
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.
T. Mosmann (1989)
10.1016/S0378-5173(02)00269-7
Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid.
Soo-Jeong Lim (2002)
10.1016/J.IJPHARM.2004.03.018
Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment.
Alf Lamprecht (2004)
10.1080/02652040010018056
Production of solid lipid nanoparticles (SLN): scaling up feasibilities
A. Dingler (2002)
10.1016/S0378-5173(02)00684-1
Cosmetic applications for solid lipid nanoparticles (SLN).
S. Wissing (2003)
10.1016/J.JCONREL.2004.07.030
Transmucosal macromolecular drug delivery.
C. Prego (2005)
10.1016/J.BPC.2004.11.016
Membrane destabilizing properties of cell-penetrating peptides.
P. Thoren (2005)
10.1016/S0168-3659(97)00046-1
Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential
K. Westesen (1997)
10.1016/S0168-3659(99)00048-6
Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect.
Y. Kawashima (1999)
10.1080/1061186021000001832
Lipid-Drug-Conjugate (LDC) Nanoparticles as Novel Carrier System for the Hydrophilic Antitrypanosomal Drug Diminazenediaceturate
C. Olbrich (2002)
10.1016/S0928-0987(03)00019-8
Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha.
A. Sánchez (2003)
10.1016/0264-410X(93)90190-9
Adjuvants--a balance between toxicity and adjuvanticity.
R. Gupta (1993)
10.1021/BI0491604
The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
A. Ziegler (2005)
10.1016/S0169-409X(02)00118-7
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
R. Mueller (2002)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1016/S0168-3659(02)00275-4
Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres.
Manish Diwan (2002)
10.1016/J.JCONREL.2003.11.012
Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
K. Jores (2004)
10.1016/J.JCONREL.2004.02.029
Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes.
K. Tabatt (2004)
10.1016/S0378-5173(03)00138-8
Interactions of amphiphilic calix[4]arene-based Solid Lipid Nanoparticles with bovine serum albumin.
Jérôme Gualbert (2003)
10.1016/J.IJPHARM.2003.12.016
Preparation and characterization of solid lipid nanoparticles containing peptide.
F. Hu (2004)
10.1007/s11095-004-1196-0
Influence of Lipid Nanocapsules Composition on Their Aptness to Freeze-Drying
C. Dulieu (2004)
10.1023/A:1018922114398
Site-Specific Drug Delivery to Pilosebaceous Structures Using Polymeric Microspheres
A. Rolland (2004)
10.1006/PHRS.2000.0695
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats.
A. Fundaró (2000)
10.1021/JM950802I
Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery.
J. Wang (1998)
10.1016/J.IJPHARM.2004.04.020
Formulation and characterization of bupivacaine lipospheres.
S. Toongsuwan (2004)
10.1166/JBN.2005.010
Sustained Proangiogenic Activity of Vascular Endothelial Growth Factor Following Encapsulation in Nanoparticles
Jasmine Davda (2005)
10.1016/J.IJPHARM.2003.10.038
Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge.
A. Kohli (2004)
10.1016/S0378-5173(96)04779-5
Lipid nanoparticles for delivering antitumor drugs
N. Hodoshima (1997)
10.1016/S0378-5173(01)00882-1
Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages.
N. Schöler (2002)
10.1016/S0378-5173(97)04890-4
Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles
K. Westesen (1997)
10.1016/0378-5173(95)04388-8
Thymopentin in solid lipid nanoparticles
S. Morel (1996)
10.1016/S0168-3659(97)00105-3
Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats.
R. Löbenberg (1998)
10.1016/S0142-9612(01)00362-3
Production of lipospheres as carriers for bioactive compounds.
R. Cortesi (2002)
10.1016/J.IJPHARM.2005.02.005
Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN).
E. Souto (2005)
10.1016/J.EJPB.2005.09.003
Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands.
N. Pedersen (2006)
10.1016/S0168-3659(02)00127-X
Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.
S. Sahoo (2002)
10.1016/S0168-3659(01)00506-5
Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA.
C. Olbrich (2001)
10.1016/S0009-3084(97)00020-0
Novel cationic liposomes for DNA-transfection with high efficiency and low toxicity.
T. Paukku (1997)
10.1073/PNAS.93.21.11454
A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung.
C. Wheeler (1996)
10.1016/0378-5173(95)04353-5
The effect of adsorbed poloxamer 188 and 407 surfactants on the intestinal uptake of 60-nm polystyrene particles after oral administration in the rat
A. M. Hillery (1996)
10.1023/A:1018986226557
Preparation and Characterization of Novel Poly(methylidene Malonate 2.1.2.)-Made Nanoparticles
F. Lescure (2004)
10.1016/S0378-5173(02)00080-7
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin.
R. Cavalli (2002)
10.1016/S0378-5173(02)00002-9
Effects of formulation variables on characteristics of poly (ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions.
S. Watnasirichaikul (2002)
10.1016/J.VACCINE.2003.10.020
Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles.
A. M. Carcaboso (2004)
10.1080/02652040500162378
A novel approach based on lipid nanoparticles (SLN®) for topical delivery of α-lipoic acid
E. Souto (2005)
10.1016/J.IJPHARM.2004.02.032
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
E. Souto (2004)
10.1016/S0165-6147(03)00073-7
Cell microencapsulation technology for biomedical purposes: novel insights and challenges.
G. Orive (2003)
10.1080/713817583
Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization
V. Jenning (2002)
10.1016/J.IJBIOMAC.2005.05.003
A new healthy sunscreen system for human: solid lipid nanoparticles as carrier for 3,4,5-trimethoxybenzoylchitin and the improvement by adding Vitamin E.
Chunjin Song (2005)
10.1016/J.ULTSONCH.2004.10.004
Continuous contact- and contamination-free ultrasonic emulsification-a useful tool for pharmaceutical development and production.
S. Freitas (2006)
Drug release and release mechanism of prednisolone loaded Solid Lipid Nanoparticles
A. Z. Mühlen (1998)
10.1016/S0034-5288(02)00180-7
Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice.
M. Shephard (2003)
10.1016/J.JCONREL.2005.02.028
Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice.
L. Harivardhan Reddy (2005)
10.1016/S0939-6411(97)00098-2
Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract
G. Ponchel (1997)
10.1021/BI00041A033
A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery.
I. Solodin (1995)
10.1097/00000441-198910000-00013
In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle.
K. Brigham (1989)
10.1021/JS950164R
Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement.
J. Molpeceres (1996)
10.3109/02652049809006847
Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization.
H. Heiati (1998)
10.1002/JPS.20057
Cyclosporin nanoparticulate lipospheres for oral administration.
Tania Bekerman (2004)
10.1163/1568562041753098
Design and characterisation of new nanoparticulate polymer blends for drug delivery
N. Csaba (2004)
10.1016/J.VACCINE.2003.12.032
Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.
Praveen Elamanchili (2004)
10.1016/J.COPBIO.2005.10.009
Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery.
V. Labhasetwar (2005)
10.1038/sj.gt.3300473
Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC
CM Gorman (1997)
10.1016/S0927-7765(02)00053-X
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
M. Garcia-Fuentes (2003)
10.1023/A:1011042627714
Incorporation of the Model Drug Ubidecarenone into Solid Lipid Nanoparticles
H. Bunjes (2004)
10.1016/0378-5173(94)90466-9
Incorporation in lipospheres of [d-Trp-6]LHRH
S. Morel (1994)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar